
Patricia Ann Duffy
Examiner (ID: 7333)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1806, 1648, 1802, 1645, 1818 |
| Total Applications | 1671 |
| Issued Applications | 766 |
| Pending Applications | 244 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5010478
[patent_doc_number] => 20070280957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Change of the Load State of Mhc Molecules'
[patent_app_type] => utility
[patent_app_number] => 11/663146
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 32256
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20070280957.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663146
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663146 | Change of the Load State of Mhc Molecules | Sep 15, 2005 | Abandoned |
Array
(
[id] => 5514260
[patent_doc_number] => 20090214566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Protective anti-glucan antibodies with preference for beta-1,3- glucans'
[patent_app_type] => utility
[patent_app_number] => 11/662880
[patent_app_country] => US
[patent_app_date] => 2005-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10213
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214566.pdf
[firstpage_image] =>[orig_patent_app_number] => 11662880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/662880 | Protective anti-glucan antibodies with preference for β-1,3- glucans | Sep 13, 2005 | Issued |
Array
(
[id] => 4563098
[patent_doc_number] => 07846662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Method of screening Baff suppressor or inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/662795
[patent_app_country] => US
[patent_app_date] => 2005-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5642
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/846/07846662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11662795
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/662795 | Method of screening Baff suppressor or inhibitor | Sep 13, 2005 | Issued |
Array
(
[id] => 5045605
[patent_doc_number] => 20070264278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus'
[patent_app_type] => utility
[patent_app_number] => 11/663037
[patent_app_country] => US
[patent_app_date] => 2005-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6408
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264278.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663037
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663037 | Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus | Sep 12, 2005 | Abandoned |
Array
(
[id] => 9620485
[patent_doc_number] => 08790654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-29
[patent_title] => 'Glycosylceramide adjuvant for saccharide antigens'
[patent_app_type] => utility
[patent_app_number] => 11/662371
[patent_app_country] => US
[patent_app_date] => 2005-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 19
[patent_no_of_words] => 10747
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11662371
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/662371 | Glycosylceramide adjuvant for saccharide antigens | Sep 6, 2005 | Issued |
Array
(
[id] => 5199690
[patent_doc_number] => 20070299008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells'
[patent_app_type] => utility
[patent_app_number] => 11/661849
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7483
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299008.pdf
[firstpage_image] =>[orig_patent_app_number] => 11661849
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/661849 | Transport protein which is used to introduce chemical compounds into nerve cells | Sep 5, 2005 | Issued |
Array
(
[id] => 4733402
[patent_doc_number] => 20080050381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Antihuman Baff Antibody'
[patent_app_type] => utility
[patent_app_number] => 11/661260
[patent_app_country] => US
[patent_app_date] => 2005-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5831
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050381.pdf
[firstpage_image] =>[orig_patent_app_number] => 11661260
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/661260 | Antihuman Baff Antibody | Aug 29, 2005 | Abandoned |
Array
(
[id] => 5874226
[patent_doc_number] => 20060166276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Method of diagnosis and agents useful for same'
[patent_app_type] => utility
[patent_app_number] => 11/215839
[patent_app_country] => US
[patent_app_date] => 2005-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 19506
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166276.pdf
[firstpage_image] =>[orig_patent_app_number] => 11215839
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/215839 | Method of diagnosis and agents useful for same | Aug 28, 2005 | Abandoned |
Array
(
[id] => 5141337
[patent_doc_number] => 20070003553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Anticoagulant agents useful in treatment of thrombosis'
[patent_app_type] => utility
[patent_app_number] => 11/201592
[patent_app_country] => US
[patent_app_date] => 2005-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16763
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003553.pdf
[firstpage_image] =>[orig_patent_app_number] => 11201592
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/201592 | Anticoagulant agents useful in treatment of thrombosis | Aug 10, 2005 | Abandoned |
Array
(
[id] => 7247260
[patent_doc_number] => 20050272089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Critical genes and polypeptides of haemophilus influenzae and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/194246
[patent_app_country] => US
[patent_app_date] => 2005-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 131
[patent_figures_cnt] => 131
[patent_no_of_words] => 23402
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272089.pdf
[firstpage_image] =>[orig_patent_app_number] => 11194246
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/194246 | Critical genes and polypeptides of haemophilus influenzae and methods of use | Jul 31, 2005 | Abandoned |
Array
(
[id] => 5119361
[patent_doc_number] => 20070141075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Plasmodium vivax blood stage antigens, PVESP-1, antibodies and diagnostic assays'
[patent_app_type] => utility
[patent_app_number] => 11/187736
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8334
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141075.pdf
[firstpage_image] =>[orig_patent_app_number] => 11187736
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/187736 | Plasmodium vivax blood stage antigens, PVESP-1, antibodies and diagnostic assays | Jul 21, 2005 | Abandoned |
Array
(
[id] => 5661019
[patent_doc_number] => 20060251615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Therapeutic agent for preventing and/or treating sepsis'
[patent_app_type] => utility
[patent_app_number] => 11/186638
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2387
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251615.pdf
[firstpage_image] =>[orig_patent_app_number] => 11186638
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/186638 | Therapeutic agent for preventing and/or treating sepsis | Jul 20, 2005 | Abandoned |
Array
(
[id] => 5336687
[patent_doc_number] => 20090053151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Antibacterial peptides and analogues thereof'
[patent_app_type] => utility
[patent_app_number] => 11/632449
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9858
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053151.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632449
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632449 | Antibacterial peptides and analogues thereof | Jul 12, 2005 | Issued |
Array
(
[id] => 5581353
[patent_doc_number] => 20090176699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Inhibitors Based on Fusion, Hr1 and Hr2 Sequences in Bacterial Adhesin'
[patent_app_type] => utility
[patent_app_number] => 11/631807
[patent_app_country] => US
[patent_app_date] => 2005-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8264
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176699.pdf
[firstpage_image] =>[orig_patent_app_number] => 11631807
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/631807 | Inhibitors Based on Fusion, Hr1 and Hr2 Sequences in Bacterial Adhesin | Jul 5, 2005 | Abandoned |
Array
(
[id] => 4718661
[patent_doc_number] => 20080241183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Process For The Preparation And Use Of A Bivalent Vaccine Against Morphine-Heroine Addiction'
[patent_app_type] => utility
[patent_app_number] => 11/632085
[patent_app_country] => US
[patent_app_date] => 2005-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19646
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632085
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632085 | Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction | Jul 4, 2005 | Issued |
Array
(
[id] => 5015689
[patent_doc_number] => 20070258897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Antibodies Against Bacterial Antigens and Their Use in the Generation of Immune Responses Against Apoptotic Cells'
[patent_app_type] => utility
[patent_app_number] => 11/630444
[patent_app_country] => US
[patent_app_date] => 2005-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12064
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20070258897.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630444
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630444 | Antibodies Against Bacterial Antigens and Their Use in the Generation of Immune Responses Against Apoptotic Cells | Jun 22, 2005 | Abandoned |
Array
(
[id] => 169829
[patent_doc_number] => 07662391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Chlamydia outer membrane protein (OMP) and vaccine uses of the protein'
[patent_app_type] => utility
[patent_app_number] => 11/142306
[patent_app_country] => US
[patent_app_date] => 2005-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15991
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662391.pdf
[firstpage_image] =>[orig_patent_app_number] => 11142306
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/142306 | Chlamydia outer membrane protein (OMP) and vaccine uses of the protein | Jun 1, 2005 | Issued |
Array
(
[id] => 4663083
[patent_doc_number] => 20080253990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Self-Containing Lactobacillus Strain'
[patent_app_type] => utility
[patent_app_number] => 11/596715
[patent_app_country] => US
[patent_app_date] => 2005-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6241
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20080253990.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596715 | Self-Containing Lactobacillus Strain | May 17, 2005 | Abandoned |
Array
(
[id] => 4785030
[patent_doc_number] => 20080138359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Neisseria meningitidis lgtb Los as Adjuvant'
[patent_app_type] => utility
[patent_app_number] => 11/596319
[patent_app_country] => US
[patent_app_date] => 2005-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5814
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138359.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596319
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596319 | Neisseria meningitidis lgtb Los as Adjuvant | May 10, 2005 | Abandoned |
Array
(
[id] => 7056002
[patent_doc_number] => 20050277176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Human and mouse beta-defensins, antimicrobial peptides'
[patent_app_type] => utility
[patent_app_number] => 11/121301
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 32110
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20050277176.pdf
[firstpage_image] =>[orig_patent_app_number] => 11121301
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/121301 | Human and mouse beta-defensins, antimicrobial peptides | May 2, 2005 | Abandoned |